This provider's $5.5M in total Medicare payments ranks in the 83th percentile of Clinical Laboratory providers nationally.
This provider's billing patterns fall within normal ranges for their specialty.
AI-generated analysis based on Medicare payment data.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2022 | $521.31 | $374.69 | 1.39x | $146.62 | $4.0M | 10.6K | 10.6K |
| 2023 | $515.97 | $374.06 | 1.38x | $141.91 | $1.5M | 4.0K | 4.0K |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| 81307 | Gene analysis (partner and localizer of brca2) full sequence analysis | 1.4K | $909.6K | $662.97 | 1.45x |
| 81317 | Gene analysis (postmeiotic segregation increased 2 [s cerevisiae]) full sequence analysis | 1.3K | $861.9K | $662.97 | 1.02x |
| 81249 | Gene analysis (glucose-6-phosphate dehydrogenase) full sequence analysis | 1.3K | $738.5K | $588.00 | 1.02x |
| 81298 | Gene analysis (muts homolog 6 [e coli]) full sequence analysis | 1.2K | $732.2K | $629.01 | 1.02x |
| 81238 | Gene analysis (coagulation factor ix) full sequence analysis | 1.2K | $696.2K | $588.00 | 2.04x |
| 81223 | Gene analysis (cystic fibrosis transmembrane conductance regular) full gene sequence | 1.2K | $608.8K | $489.02 | 2.04x |
| 81339 | Gene analysis (mpl proto-oncogene, thrombopoietin receptor) sequence analysis of exon 10 | 1.3K | $241.4K | $181.50 | 1.02x |
| 81279 | Gene analysis (janus kinase 2) targeted sequence analysis | 1.3K | $241.4K | $181.50 | 1.02x |
| 81432 | Test for detecting genes associated with inherited breast cancer-related disorders | 184 | $122.4K | $665.47 | 1.02x |
| 81435 | Test for detecting genes associated with colon cancer, genomic sequence analysis panel, at least 10 genes | 194 | $111.2K | $573.20 | 1.02x |
| 81250 | Gene analysis (glucose-6-phosphatase, catalytic subunit) common variants | 1.3K | $73.1K | $57.32 | 2.04x |
| 81209 | Gene analysis (bloom syndrome, recq helicase-like) | 1.2K | $46.9K | $38.52 | 1.02x |
| 81300 | Gene analysis (muts homolog 6 [e coli]) duplication or deletion variants | 189 | $44.1K | $233.24 | 1.24x |
| 81242 | Gene analysis (fanconi anemia, complementation group c) common variant | 1.2K | $42.9K | $35.89 | 2.04x |
| 81319 | Gene analysis (postmeiotic segregation increased 2 [s cerevisiae]) duplication or deletion variants | 189 | $37.7K | $199.43 | 1.25x |
| 81297 | Gene analysis (muts homolog 2, colon cancer, nonpolyposis type 1) duplication or deletion variants | 19 | $4.0K | $209.03 | 4.12x |
This provider submits charges 1.36 times higher than what Medicare actually pays.
A markup ratio of 1.36x means for every $100 Medicare pays, this provider initially charges $136. This is lower than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Clinical Laboratory providers in TX for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Clinical Pathology Laboratories, Inc. | Austin, TX | $541.0M | ⚠️ Flagged |
| Quest Diagnostics Clinical Laboratories Inc | Irving, TX | $453.2M | ⚠️ Flagged |
| Laboratory Corporation Of America | Dallas, TX | $389.6M | ⚠️ Flagged |
| Quest Diagnostics Clinical Laboratories Inc | Houston, TX | $311.2M | ⚠️ Flagged |
| Laboratory Corporation Of America | Houston, TX | $299.4M | ⚠️ Flagged |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data